# Pavillion Capital

> Pavillion Capital is a VC fund in London backing Software and Financial Services. See 7 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: London, United Kingdom
- Total investments: 7
- Last investment: Jun 2021
- Lead investor: 29%
- Last updated: Aug 2026
- Website: http://pavillioncapital.co.uk

Pavillion Capital is a VC fund in London focused on Software and Financial Services. Pavillion Capital Partners Limited is a boutique solutions company operating across a wide range of market sectors and disciplines.Their core activites are Finance, Corporate Services and Commercial Real Estate.Whether it be a Finance Requirement, Corporate Strategy Review or a Real Estate matter, Pavillion welcomes enquiries from both thePrivate and Institutional sectors.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 3 | 43% |
| Financial Services | 3 | 43% |
| Finance | 2 | 29% |
| Health Care | 2 | 29% |
| Therapeutics | 2 | 29% |

25 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 4 | 57% |
| Series C | 2 | 29% |
| Series D | 1 | 14% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 3 | 43% |
| United States | 3 | 43% |
| Japan | 1 | 14% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Circle Pharma | Circle Pharma is an early-stage biotechnology company applying proprietary computational design algorithms and innovative chemistry to develop cell-permeable macrocycle peptide therapeutics against important clinical targets. It does this through an iterative, rational design process that deploys large virtual libraries of conformationally diversemacrocycle scaffolds selected for inherent permeability. The company was founded by Matt Jacobson and Scott Lokey in 2012 and is headed by David J. Earp. | $66M | Series C | Jun 16, 2021 |  |
| Zilliz | Zilliz was founded in 2017 and operates as a distributed team with offices in both the U.S. and China. The company specializes in the development of open-source, AI-powered unstructured data analysis software, and is the initiator and primary contributor to the vector similarity search project Milvus. Milvus was released under an open-sourcelicense in October 2019. It has been “starred” over 4,400 times on GitHub and engaged 120+ contributors. Milvus has been adopted by 400+ enterprise users, with applications spanning image processing, computer vision, natural language processing (NLP), speech recognition, recommendation engines, search engines, new drug development, gene analysis, and more. In April 2020, Milvus became an incubation-stage project at the LF AI & Data Foundation, and currently has more commits than any other project in the incubator. | $43M | Series B | Nov 16, 2020 |  |
| Tradeshift | Tradeshift is a cloud-based business network connecting buyers and suppliers. Its platform enables its clients to connect with all their suppliers digitally in order to seize early payment discounts and minimize risks, eliminating paper and manual processes across procure-to-pay, thereby allowing businesses to simplify supply chain payments in asecure manner. | $75M | Series D | Jun 09, 2016 |  |
| Ascletis | Ascletis is a joint venture between U.S. and Chinese entrepreneurs aimed at building a global specialty therapeutics business dedicated to discovering and developing important new treatments for cancer and infectious diseases. Ascletis leverages U.S./European innovation and pharmaceutical/biotech strategic experience and China'scapital efficiency with a goal of establishing in the near term a sustainable business and accelerated revenues through the in-licensing, late-stage clinical development, and commercialization of new medicines for the growing Chinese pharmaceutical marketplace. At the same time, the company is building long-term value through the discovery, demonstration of clinical proof-of-concept, and global partnering of novel therapeutics for life-threatening diseases. | $35M | Series B | Sep 02, 2015 |  |
| Freee | freee is automated online accounting software that syncs with your bank accounts and automatically categorise entries to create financial reports. freee was launched on Mar 19, 2013 and is offered to SMBs operating under the Japanese taxation system. It takes freemium model and its paid plan begins at 980 JPY (~10 USD) per month per business.The company, formerly named as “CFO K.K.”, was founded in July 2012 led by Daisuke Sasaki, who previously headed up Google’s SMB marketing in Asia Pasific region. freee is the winner of Invinity Ventures Summit Launch Pad 2013 Spring, the most prestegious demo event in Japan. | $6M | Series B | Sep 25, 2014 |  |
| Rong360 | Rong 360 is a Chinese provider of customized financing and loan services. The company enables users to search and compare loan products from various banks and lending agencies. Rong 360 allows users to make direct contact with bank business personnel, while building an all-around direct selling platform of financing and loan products. | $60M | Series C | Jul 23, 2014 |  |
| Yodo1 | Yodo1 is a game platform company that helps developers better market, manage, and monetize their games. Our AI-powered tools and global expertise in areas such as mobile advertising, community management, and digital IP licensing enable partners to increase playtime, revenue, and retention. Starting with our own titles—including Rodeo Stampede,Transformers: Earth Wars, and Crossy Roads—we learned to publish successfully worldwide and in China. Our signature East-meets-West approach helped us amass over 1.5 billion players and has driven the creation of unique, world-class game management, marketing, and monetization tools. | $11M | Series B | Dec 10, 2013 |  |

7 of 7 investments shown.

## Co-investors
- [Nextech Invest](https://shizune.co/investors/profile/nextech-invest) — VC Fund, 2 deals together
- [Amex Ventures](https://shizune.co/investors/profile/american-express-ventures) — VC Fund, 1 deal together
- [C-Bridge Capital](https://shizune.co/investors/profile/cbridge-capital) — VC Fund, 1 deal together
- [CreditEase](https://shizune.co/investors/profile/creditease) — VC Fund, 1 deal together
- [CE Innovation Capital](https://shizune.co/investors/profile/creditease-fintech-investment-fund) — VC Fund, 1 deal together
- [DCVC](https://shizune.co/investors/profile/data-collective) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Pavillion Capital invest in?

Pavillion Capital invests primarily in Software, Financial Services and Finance startups, most often at Series B and Series C stage. Most of the 7 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Pavillion Capital last invest?

The most recent investment recorded for Pavillion Capital closed in Jun 2021. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co